Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes

被引:23
作者
Nozaki, Maiko [1 ]
Fukuhara, Atsunori [1 ]
Segawa, Katsumori [1 ]
Okuno, Yosuke [1 ]
Abe, Manabu [1 ]
Hosogai, Naomi [1 ]
Matsuda, Morihiro [1 ]
Komuro, Ryutaro [1 ]
Shimomura, Iichiro [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
关键词
obesity; nitric oxide; adiponectin; PAI-1; IL-6;
D O I
10.1016/j.bbrc.2007.09.084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is associated with infiltration of macrophages into adipose tissue, and macrophages are an important source of nitric oxide (NO). Dysregulated production of fat-derived secretory factor, adipocytokine, leads to obesity-linked metabolic disorders. However, it has not been fully determined whether NO might have direct effects on adipocytokine expressions. Here, we show that NO donor treatment downregulated gene expression and secretion of adiponectin, and upregulated mRNA levels of PAI-1 and IL-6. NO donor reduced promoter activity of adiponectin through PPAR gamma responsive element. Moreover, NO donor activated JNK and NF-kappa B pathways, and inhibitors of these pathways rescued NO-mediated upregulation of PAI-1 and IL-6. Analysis of adipose tissue of high-fat-fed obese mice showed upregulation of PAI-1 and IL-6 expression, increased synthesis of NO, and downregulation of adiponectin. Our results suggest that increased NO synthesis might be partly responsible for dysregulation of adipocytokines in adipose tissue. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 37 条
[1]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89
[2]  
Choi JW, 2001, CLIN CHEM, V47, P1106
[3]   Bone marrow plasminogen activator inhibitor-1 influences the development of obesity [J].
De Taeye, Bart M. ;
Novitskaya, Tatiana ;
Gleaves, Linda ;
Covington, Joseph W. ;
Vaughan, Douglas E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (43) :32796-32805
[4]   Regulation of the nitric oxide system in human adipose tissue [J].
Engeli, S ;
Janke, J ;
Gorzelniak, K ;
Böhnke, J ;
Ghose, N ;
Lindschau, C ;
Luft, FC ;
Sharma, AM .
JOURNAL OF LIPID RESEARCH, 2004, 45 (09) :1640-1648
[5]   Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Klein, J ;
Neumann, S ;
Eszlinger, M ;
Paschke, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (03) :1084-1089
[6]  
Ferlito S, 1999, Minerva Endocrinol, V24, P117
[7]  
Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189
[8]   A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice [J].
Fujimoto, M ;
Shimizu, N ;
Kunii, K ;
Martyn, JAJ ;
Ueki, K ;
Kaneki, M .
DIABETES, 2005, 54 (05) :1340-1348
[9]   Increased oxidative stress in obesity and its impact on metabolic syndrome [J].
Furukawa, S ;
Fujita, T ;
Shimabukuro, M ;
Iwaki, M ;
Yamada, Y ;
Nakajima, Y ;
Nakayama, O ;
Makishima, M ;
Matsuda, M ;
Shimomura, I .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1752-1761
[10]   Reduced adipose tissue mass and hypoleptinemia in NOS deficient mice:: effect of LPS on plasma leptin and adiponectin concentrations [J].
Gómez-Ambrosi, J ;
Becerril, S ;
Oroz, P ;
Zabalza, S ;
Rodríguez, A ;
Muruzábal, FJ ;
Archanco, M ;
Gil, MJ ;
Burrell, MA ;
Frühbeck, G .
FEBS LETTERS, 2004, 577 (03) :351-356